Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» opioid use disorder
opioid use disorder
GLP-1 Drugs Show Promise in Alcohol, Opioid Use Disorders
BioSpace
Thu, 08/3/23 - 10:05 am
GLP-1 agonist
alcohol-use disorder
opioid use disorder
FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder
Fierce Pharma
Wed, 05/24/23 - 06:38 pm
Braeburn Pharmaceuticals
FDA
Brixadi
opioids
opioid use disorder
Black patients far less likely to receive key opioid addiction medication, study finds
Stat
Wed, 05/10/23 - 11:09 pm
opioid addiction
opioid use disorder
buprenorphine
racial disparity
Ohio is third state to fund Pear’s digital therapeutics to tackle addiction
Pharmaforum
Fri, 04/23/21 - 10:56 am
Pear Therapeutics
digital pharma
digital therapeutics
opioid use disorder
Ohio
Orexo eyes real-world testing of its modia opioid use disorder app
Pharmaforum
Fri, 02/12/21 - 10:41 am
Orexo
opioids
opioid use disorder
digital therapeutics
cognitive behavioral therapy
Modia
Trump administration will let nearly all doctors prescribe addiction medicine buprenorphine
Stat
Fri, 01/15/21 - 08:32 am
opioid use disorder
opioid addiction
opioids
Donald Trump
buprenorphine
physicians
Orexo eyes opioid use disorder app launch before year-end
Pharmaforum
Fri, 10/2/20 - 01:02 pm
Orexo
opioid use disorder
opioids
digital therapeutics
FDA to Revoke Orphan Designation for Opioid Addiction Drug Sublocade
RAPS.org
Sun, 11/10/19 - 07:46 pm
FDA
orphan drugs
Indivior
Sublocade
opioid use disorder
Orexo partners with Gaia on digital opioid abuse therapeutic
Pharmaforum
Fri, 08/23/19 - 09:53 am
Orexo
Gaia Healthcare
digital therapeutics
opioid use disorder
opioid addiction
BioCorRx wins $5.6m grant for sustained release naltrexone implant
Drug Delivery Business News
Mon, 01/28/19 - 10:49 pm
devices
BioCorRx
NIH
naltrexone implant
opioid use disorder
opioid addiction